Literature DB >> 10223610

Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis.

K M Thickett, M J Wildman, C D Fegan, D E Stableforth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10223610     DOI： 10.1093/jac/43.3.435

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.

Authors:  S Kunzmann; W Thomas; B Mayer; S Kuhn; H Hebestreit
Journal:  Infection       Date:  2010-03-05       Impact factor: 3.553

2.  Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.

Authors:  Carolin Meinus; Carsten Schwarz; Beate Mayer; J F Roehmel
Journal:  BMJ Case Rep       Date:  2016-10-24

Review 3.  The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Authors:  D Banerjee; D Stableforth
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.

Authors:  Mahesh Bandara; David B Seder; George Garratty; Regina M Leger; Jonathan B Zuckerman
Journal:  Case Rep Med       Date:  2010-06-02

5.  Piperacillin induced bone marrow suppression: a case report.

Authors:  Ashish Kumar; Gourdas Choudhuri; Rakesh Aggarwal
Journal:  BMC Clin Pharmacol       Date:  2003-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.